Foamix

$3.24
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.00 (0.15%) As of 1:12 PM EDT today
+$0.00 (0.15%) Today

Why Robinhood?

You can buy or sell Foamix and other stocks, options, ETFs, and crypto commission-free!

About FOMX

Foamix Pharmaceuticals Ltd. Ordinary Shares, also called Foamix, is a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Read More Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel.

Employees
81
Headquarters
Rehovot, HaMerkaz
Founded
2003
Market Cap
197.04M
Price-Earnings Ratio
Dividend Yield
Average Volume
1.28M
High Today
$3.35
Low Today
$3.07
Open Price
$3.20
Volume
925.18K
52 Week High
$7.60
52 Week Low
$1.97

Collections

FOMX Earnings

-$0.69
-$0.53
-$0.36
-$0.20
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 6, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.